# Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

> **NCT00910143** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 194 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** conventional rectal surgery
- **PROCEDURE:** total mesorectal excision

## Key facts

- **NCT ID:** NCT00910143
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1993-01
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2009-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910143, "Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00910143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*